Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials
call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or
email cancerclinicaltrials@bsd.uchicago.edu.

This study is a Phase 1, Non-randomized, Open-label/Phase 2 Randomized, Blinded Study of
ProTmune (ex vivo programmed mobilized peripheral blood cells) Versus Non-programmed
mobilized peripheral blood cells for Allogeneic Hematopoietic Cell Transplantation (HCT) in
Adult Subjects Aged 18 to 70 years with Hematologic Malignancies. A maximum of 70 total
eligible subjects will be enrolled and treated in the trial at approximately 15-20 centers in
the US and EU.